Sequential recovery of NK cell receptor repertoire after allogeneic hematopoietic SCT
- 1 February 2010
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 45 (6) , 1022-1030
Abstract
Alloreactivity of natural killer (NK) cells contributes to the GVL reaction after allogeneic hematopoietic SCT (allo-HSCT). However, various procedure-related factors may affect NK cell maturation and their ability to recognize and kill leukemic cells. In this study, we prospectively evaluated expression of NK cell inhibitory receptors in 83 adults treated with myeloablative, killer cell Ig-like receptor (KIR)-ligand-matched allo-HSCT. NK cell maturation was evaluated by comparing the phenotypic patterns after allo-HSCT with the donor ones. The frequencies of KIR3DL1 were comparable to the donor ones on day +28, while they decreased significantly starting from day +100. The expression of KIR2DL2/3 was significantly lower in patients compared with donors up to day +100. The expression of KIR2DL1, despite continues growth, remained significantly decreased for 1 year after allo-HSCT. NKG2A was over-expressed up to day +180. Within 1 year after allo-HSCT, the NK cell phenotypic pattern tended to recapitulate the donor type. The process was disturbed by the use of steroids with significant differences observed on days +56 (P=0.01) and +100 (P=0.04). Up to day +100, reconstitution of NK cell receptor repertoire correlated with the absolute numbers of circulating CD3+, CD3+CD4+ and CD3+CD8+ cells. Our observations should be taken into account when trying to predict potential benefit from NK cell alloreactivity.Keywords
This publication has 33 references indexed in Scilit:
- KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemiaLeukemia, 2009
- Treosulfan and fludarabine low‐toxicity conditioning for allogeneic haematopoietic stem cell transplantation in chronic myeloid leukaemiaBritish Journal of Haematology, 2008
- Effects of HLA Allele and Killer Immunoglobulin-Like Receptor Ligand Matching on Clinical Outcome in Leukemia Patients Undergoing Transplantation With T-cell–Replete Marrow From an Unrelated DonorTransplantation and Cellular Therapy, 2007
- Deleterious effects of KIR ligand incompatibility on clinical outcomes in haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletionLeukemia, 2007
- Natural killer cell HLA‐C epitopes and killer cell immunoglobulin‐like receptors both influence outcome of mismatched unrelated donor bone marrow transplantsTissue Antigens, 2005
- Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemiasBlood, 2005
- The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor‐alloreactive T cells causing GVHDTissue Antigens, 2004
- Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplantsBlood, 2002
- Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effectBlood, 2002
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002